RCN1 and glioblastoma: Since several clinical characteristics have been identified to influence the outcomes of GBM patients, interaction may exist (Brankovic et al., 2019) and it is plausible to perform subgroup analysis to estimate the interaction between RCN1 and selective clinical characteristics (Gönen, 2003).